` Comparison: 538634 vs SUNPHARMA - Alpha Spread

V
538634
vs
SUNPHARMA

Over the past 12 months, VRL has underperformed SUNPHARMA, delivering a return of -53% compared to the SUNPHARMA's +6% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
538634
SUNPHARMA
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

V
VRL Intrinsic Value
167.04 INR
Undervaluation 30%
Intrinsic Value
Price
SUNPHARMA Intrinsic Value
1 170.27 INR
Overvaluation 35%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
V
Vasundhara Rasayans Ltd
BSE:538634
117.4 INR
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
1 802.3 INR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
538634, SUNPHARMA

538634
SUNPHARMA
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
V
Vasundhara Rasayans Ltd
Revenue
Sun Pharmaceutical Industries Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
538634, SUNPHARMA

538634
SUNPHARMA
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
V
Vasundhara Rasayans Ltd
BSE:538634
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

VRL
51.8%
SUNPHARMA
80%

Operating Margin

VRL
7.7%
SUNPHARMA
23.9%

Net Margin

VRL
11.8%
SUNPHARMA
19.2%

FCF Margin

VRL
-13.9%
SUNPHARMA
15.7%

ROE

VRL
9.8%
SUNPHARMA
14.9%

ROA

VRL
8.1%
SUNPHARMA
11.4%

ROIC

VRL
4.5%
SUNPHARMA
15%

ROCE

VRL
6.3%
SUNPHARMA
17.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
538634, SUNPHARMA

Loading
538634
SUNPHARMA
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
538634, SUNPHARMA

Loading
538634
SUNPHARMA
Difference
www.alphaspread.com

Performance By Year
538634, SUNPHARMA

Loading
538634
SUNPHARMA
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 538634 to other stocks
SDZ
Sandoz Group AG
S
More expensive
vs VRL
DD
Dupont De Nemours Inc
More expensive
vs VRL
002001
Zhejiang Nhu Co Ltd
More expensive
vs VRL
300765
CSPC Innovation Pharmaceutical...
C
More expensive
vs VRL
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett